C - Chemistry – Metallurgy – 12 – Q
Patent
C - Chemistry, Metallurgy
12
Q
C12Q 1/48 (2006.01) C12N 9/12 (2006.01) C12Q 1/00 (2006.01) C12Q 1/02 (2006.01) G01N 33/53 (2006.01)
Patent
CA 2506634
Human CSNK genes are identified as modulators of the RAC pathway, and thus are therapeutic targets for disorders associated with defective RAC function. Methods for identifying modulators of RAC, comprising screening for agents that modulate the activity of CSNK are provided.
Des gènes MRAC humains sont identifiés comme modulateurs de la voie RB et sont, en conséquence, des cibles thérapeutiques pour des troubles associés à une fonction RAC défectueuse. L'invention concerne des procédés d'identification de modulateurs de RAC, comprenant la sélection d'agents modulant l'activité de MRAC.
Bjerke Lynn Margaret
Francis George Ross
Kadyk Lisa C.
Bennett Jones Llp
Exelixis Inc.
LandOfFree
Csnks as modifiers of the rac pathway and methods of use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Csnks as modifiers of the rac pathway and methods of use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Csnks as modifiers of the rac pathway and methods of use will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1858600